Pyocins are toxic proteins produced by some strains of Pseudomonas aeruginosa that are lethal for related strains of the same species. Some soluble pyocins (S2, S3 and S4) were previously shown to use the pyoverdine siderophore receptors to enter the cell. The P. aeruginosa PAO1 pore-forming pyocin S5 encoding gene (PAO985) was cloned into the expression vector pET15b, and the affinity-purified protein product tested for its killing activity against different P. aeruginosa strains. The results, however, did not show any correlation with a specific ferripyoverdine receptor. To further identify the S5 receptor, transposon mutants were generated. Pooled mutants were exposed to pyocin S5 and the resistant colonies growing in the killing zone were selected. The majority of S5-resistant mutants had an insertion in the fptA gene encoding the receptor for the siderophore pyochelin. Complementation of an fptA transposon mutant with the P. aeruginosa fptA gene in trans restored the sensitivity to S5. In order to define the receptorbinding domain of pyocin S5, two hybrid pyocins were constructed containing different regions from pyocin S5 fused to the C-terminal translocation and DNase killing domains of pyocin S2. Only the protein containing amino acid residues 151 to 300 from S5 showed toxicity, indicating that the pyocin S5 receptor-binding domain is not at the N-terminus of the protein as in other Stype pyocins. Pyocin S5 was, however, unable to kill Burkholderia cenocepacia strains producing a ferripyochelin FptA receptor, nor was the B. cenocepacia fptA gene able to restore the sensitivity of the resistant fptA mutant P. aeruginosa strain.
INTRODUCTION
Bacteriocins are defined as antibacterial peptides or proteins with a relatively narrow killing spectrum, as they are only toxic to bacteria closely related to the producing strain. This characteristic differentiates these allelopathic molecules from traditional antibiotics (Riley & Wertz, 2002a, b) . The mechanisms of action of bacteriocins span a very wide spectrum, from enzymic nuclease action to pore formation of the target cell. Having been discovered in virtually every lineage of prokaryotes studied to date, these toxins have been proposed to mediate intraspecific, or population-level, interactions (Klaenhammer, 1988; Riley & Gordon, 1999) . The Gram-negative bacterium Escherichia coli is one of the best documented organisms with regard to microbial allelopathy. The bacteriocins it produces, termed colicins, were first discovered and identified by the Belgian researcher André Gratia in 1925 (reviewed by Cascales et al., 2007) . The bacteriocins produced by Pseudomonas species are called pyocins, and, in contrast to colicins whose genes are plasmid-borne, the pyocin genes are found in the chromosome (Sano & Kageyama, 1984; Shinomiya et al., 1983) . Expression of the pyocin genes is induced by stress or mutagenic agents, such as UV radiation, mitomycin C treatment and treatments that cause DNA damage (Govan, 1974; Jacob, 1954; Kageyama, 1964) . There are three types of pyocins, based on their structure: R-type, F-type and S-type. The R-and F-type were the first pyocins described. They share several common features: they resemble phage tails, are protease resistant, insoluble, they are easily sedimented by ultracentrifugation, and they kill sensitive cells by depolarizing the cell membrane (Michel-Briand & Baysse, 2002) . S-type pyocins, however, are soluble toxins, protease sensitive and resemble colicins in terms of their functional organization and modes of action (Riley & Wertz, 2002b) . R-and F-type pyocins are produced by more than 90 % of Pseudomonas aeruginosa strains, while 70 % of P. aeruginosa strains can produce at least one S-type pyocin. Furthermore, strains are not limited in the number of pyocins they can produce (e.g. the PAO1 strain can produce three S-type pyocins: S2, S4 and S5) (Govan, 1974; Ling et al., 2010; Michel-Briand & Baysse, 2002; Parret & De Mot, 2002) .
Until now, six S-type pyocins from different P. aeruginosa isolates have been characterized: S1 to S5, and AP41. Similar to the organization of colicins genes, the pyocin loci encode two protein components: a larger protein bearing the killing activity and a smaller protein conferring immunity towards the producing bacteria (Duport et al., 1995; Elfarash et al., 2012; Ling et al., 2010; Michel-Briand & Baysse, 2002; Sano & Kageyama, 1984; Sano et al., 1993) . All S-type pyocins are composed of three or four domains. Like most bacteriocins, they bind to specific receptors in the bacterial outer membrane of closely related species, before being translocated through the membrane and killing their target. In contrast to colicins, the order of the receptor recognition domain and translocation domain is generally reversed: the N-terminal domain is involved in recognition of the cell surface receptor, domain II (not present in pyocin S1) has an unknown function and is dispensable for killing activity, the third domain is responsible for pyocin translocation and penetration, and the C-terminal domain carries the lethal activity (Duport et al., 1995; Michel-Briand & Baysse, 2002) .
It has been confirmed that, under iron-limited conditions (1 mM or less) P. aeruginosa strains become fully sensitive to S-type pyocins. This is explained by the appearance of ironregulated outer membrane proteins in the outer membrane of the sensitive strain (Baysse et al., 1999; Michel-Briand & Baysse, 2002) . Pyocins S2 and S4 use the type I ferripyoverdine receptor FpvAI to gain entry to sensitive strains (Denayer et al., 2007; Elfarash et al., 2012) , while pyocin S3 makes use of the type II ferri pyoverdine receptor FpvAII (Baysse et al., 1999) . In the genome of P. aeruginosa PAO1, three loci encode S-type pyocin complexes: PA1150-1151 (pyocin S2 and immunity gene), pyocin S4 (PA3866 plus non-annotated immunity gene), and PAO984-0985 (immunity gene and pyocin S5 gene). Pyocin S5 has been described and characterized by Ling et al. (2010) , who found that it has a pore-forming activity, probably due to the presence of two trans-membrane helices at the C-terminal part of the protein. The same authors also found that S5 shows a high similarity with colicin Ia and predicted the receptor-binding domain to be located at the centre of the bacteriocin (Ling et al., 2010) . Here we show that the pore-forming pyocin S5 recognizes the FptA ferripyochelin receptor of P. aeruginosa, but does not kill Burkholderia cenocepacia producing a similar FptA receptor. Furthermore, we confirmed the central localization of the receptor-binding domain of pyocin S5 by constructing and analysing the killing activity of hybrid pyocins containing the S2 DNase killing domain.
METHODS
Strains and plasmids. Bacterial strains and plasmids used in this study are described in Table 1 . Bacteria were grown at 37 uC in nutrient-rich lysogeny broth (LB) medium (Life Technologies) or in iron-poor casamino acids (CAA) medium (Difco Laboratories) (5 g casamino acids l -l , 0-9 g K 2 HPO 4 l -l , 0.25 g MgSO 4 .7H 2 O 1 -l ) and cultures were incubated in a New Brunswick Innova 4000 shaker at 200 r.p.m.
Plasmid construction. The pyocin S5 encoding gene (pyoS5, PAO985, 1496 bp) was PCR amplified from PAO1 DNA using primers S5f and S5r (Table 2 ). Amplified fragments were introduced into pET15b (+) (Merck) by NdeI/BamHI double digestion and ligation, and were used to transform E. coli BL21(DE3) pLysS. In order to determine the receptor-binding domain of the pyocin S5, we constructed two hybrid pyocins. They only differed in the fragment of S5 used in the fusion, which, in the case of S5-S2a, corresponded to the first 450 nt (150 amino acids) of the S5 gene fused to nucleotides 648-2067 of S2, while for S5-S2b, the nucleotides corresponding to amino acids 151 to 300 were fused to form the hybrid pyocin (Fig. 1) . To construct the hybrid pyocins, we separately PCR amplified the fragments of pyocin S5, and the translocation and killing domain of S2 (1419 bp), using the primers listed in Table 2 . The amplified fragments were fused by another overlapping PCR forming the final hybrid fragment that was subsequently introduced into pET24a(+) (Merck) by ligation following NdeI/SalI double digestion. The resultant plasmids expressing hybrid pyocins were used to transform E. coli BL21(DE3) pLysS.
Overexpression and purification of proteins. For protein overexpression, BL21(DE3) pLysS transformants containing the recombinant pET plasmids were induced for expression of the cloned gene by growing them overnight at 28 uC in the presence of 1.0 mM IPTG after the OD 600 reached 0.7. The harvested cells were resuspended in TGE buffer [50 mM Tris/HCl (pH 7.5), 10 % glycerol, 1 mM EDTA and 10 mM imidazole] and disrupted by pulsed sonication. The lysate was centrifuged at 20 000 r.p.m. for 15 min, and the cleared supernatant was loaded onto a Hi-Trap FF column (Amersham Biosciences, GE Healthcare) integrated by an AKTA TM FPLC system (Amersham Biosciences, GE Healthcare). The His-tagged proteins were eluted using the elution buffer containing 1M imidazole in 20 mM Tris/HCl (pH 7.5). The purity of the His-tagged proteins was verified as .95 % homogeneity after 10 % SDS-PAGE (Invitrogen). The purified proteins were dialysed against buffer containing 20 mM Tris/HCl (pH 7.5) and 150 mM NaCl. The protein concentration was determined using a NanoDrop 1000 spectrophotometer (Thermo Scientific). The pooled pure proteins were divided into small aliquots and stored at 220 uC, which were thawed individually before each manipulation.
Western blot analysis. The immunoblot analyses were performed with a horseradish peroxidase (HRP)-conjugated anti-His 6 mAb following the manufacturer's instructions (AbD Serotec, MorphoSys). Proteins from different fractions were separated by electrophoresis in 12 % SDS-PAGE gels and subsequently electro-transferred onto 0.2 mm nitrocellulose membranes (HyBond C; GE Healthcare) using a Trans-Blot immersion transfer system (90 min, 60 V; Bio-Rad). Following the transfer, the blot was stained for 1 min with Ponceau S followed by complete destaining in PBS. The membranes were subsequently blocked for 1 h at room temperature in PBS with 10 % FCS. Afterwards, the membranes were washed for 15 min with a 10 % FCS solution containing 0.1 % Tween-20 followed by incubation with the indicated dilution of HRP-conjugated detection antibody (1 in 2000) in wash buffer for 60 min at room temperature with gentle agitation. The blots were subsequently washed three times for 5 min using PBS with 0.1 % Tween-20. Protein bands were visualized using a chromogenic substrate (4-chloro-1-naphthol) and recorded by digital photography.
Pyocin sensitivity assays. To check the sensitivities of the strains to pyocins, 10 ml purified pyocin protein (15 mg ml 21 ) was spotted onto a CAA plate with a bacterial cell layer containing 5610 6 cells ml 21 and incubated at 37 uC for 24 h. Resistance was judged by the absence of a clearing zone.
Transposon mutagenesis of P. aeruginosa W15Dec1. P. aeruginosa strain W15Dec1 was subjected to a transposon mutagenesis using the miniTn5phoA3 transposon as described elsewhere (Pattery et al., 1999) . Transconjugants were selected on CAA medium plates, supplemented with gentamicin (100 mg ml
21
) and containing spectinomycin (50 mg ml 21 ) to counterselect E. coli. All mutants were pooled, plated on a CAA plate and a pyocin S5 spot assay was performed. Resistant clones that were able to grow in the clearance zone of pyocin S5 were selected. Selected mutants were tested separately, and candidates were confirmed for their S5-resistance phenotype. The site of transposon insertion was determined using inverse PCR with primers PhoA5, Gm1, PhoA4 and Gm2 as described previously (de Chial et al., 2003) . The sequence of the DNA flanking the transposon was determined at the VIB Genetic Service Facility (Antwerp, Belgium) using primers Gm2 and PhoA4.
Complementation and heterologous expression of fptA.
Biparental matings with E. coli S17-1 lpir bearing plasmid pME9629 (Hoegy et al., 2009; Michel et al., 2005) , which carries the entire fptABCX operon from P. aeruginosa (expressing the P. aeruginosa pyochelin receptor, FptA) were performed for the complementation of not only P. aeruginosa strain W15Dec1 carrying a mutation in fptA (mutant strain W15Dec1DfptA), but also B. Figurski & Helinski (1979) FptA is the pyocin S5 receptor cenocepacia strains, which show resistance to pyocin S5. Plasmid pBBR1MCS (fptA bc ), which carries fptA (BCAM2224) from B. cenocepacia, was generated as follows: a 2.4 kb XhoI-XbaI fragment, including the entire fptA coding sequence and promoter of fptA, was cloned using primers fptAf and fptAr (Table 2) , and cloned into pBBR1MCS, giving pBBR1MCS (fptA bc ), which then was introduced into E. coli S17-1 lpir to complement W15Dec1DfptA by biparental matings.
RESULTS

Pyocin S5 activity
The coding region of the pyocin S5 gene (PAO985, 1496 bp) was amplified, cloned and expressed in E. coli BL21(DE3) pLysS. After induction by IPTG and purification of the Histagged protein, a high abundance polypeptide of 56.1 kDa was detected in the soluble fraction following fractionation in SDS-PAGE gels, and by Western blot, revealing also the presence of a possible dimer at approximately 110 kDa (Fig.  S1 , available in Microbiology Online). Surprisingly, we were able to express the pyocin toxin gene (PAO985) without its immunity gene (PAO984). This could be explained by the fact that pyocin S5 has a pore-forming activity (Ling et al., 2010) , which would be active only when reaching the cell membrane from outside after recognizing a specific receptor. The purified protein was found to be active and caused the death of sensitive P. aeruginosa strains (Table 3) .
Identification of FptA as the pyocin S5 receptor
It is known that ferripyoverdine receptors are also recognized by some S pyocins. Pyocins S2 and S4 both recognize the FpvAI receptor for type I pyoverdine, while pyocin S3 kills cells expressing FpvAII (Baysse et al., 1999; de Chial et al., 2003; Denayer et al., 2007; Elfarash et al., 2012) . We first checked whether pyocin S5 would also use a ferripyoverdine receptor as port of entry. We therefore tested 61 P. aeruginosa strains with known ferripyoverdine receptor type (Bodilis et al., 2009 ) (41 environmental strains recovered from the Woluwe river and 20 clinical strains from cystic fibrosis patients) for their sensitivity to S5. The results, which are presented in Table 3 , reveal that there is no correlation between sensitivity to pyocin S5 and the presence of a particular pyoverdine receptor, excluding a possible link between the killing activity of the pyocin and the presence of a specific ferripyoverdine receptor. Only 11 strains (18 %) were resistant to S5, and of these 10 were found by PCR to contain the S5 immunity gene. In order to identify the S5 receptor, we mutagenized the S5-sensitive strain W15Dec1 by transposon mutagenesis. All mutants (.3000) were pooled and plated on CAA agar medium on which spots of S5 were applied. Wild-type cells were similarly treated. The presence of resistant colonies growing in the centre of the S5 killing zone could be detected in the plate containing the pooled transposon mutants, while no resistant clone could be detected in the plate inoculated with the wild-type (Fig. 2a) . Nineteen S5-resistant mutants were selected and the DNA sequences flanking the transposon were determined. In 17 mutants, it was found that the transposon inserted in the PA4221 gene, which encodes the FptA Fe (III)-pyochelin outer membrane receptor (Fig. 2b) . Some mutants probably corresponded to the same clone since the place of insertion was identical. Eleven mutants had insertions in different locations within fptA (Fig. 2b) . To further confirm the involvement of the FptA receptor in the uptake of pyocin S5, the W15Dec1DfptA mutant was complemented with the plasmid pME9629 (Hoegy et al., 2009; Michel et al., 2007) , which carries the entire fptABCX operon from P. aeruginosa. As expected, the complemented mutant regained sensitivity to pyocin S5 (Fig. 2c) , confirming that FptA is needed for the toxic activity of S5.
Identification of the pyocin S5 receptor-binding domain
Two fragments from the pyocin S5 gene were PCR amplified and fused to the S2 translocation and DNase domains (Fig.  1) . The two tagged hybrid pyocins were expressed in E. coli after IPTG induction (Fig. S2) . The E. coli extracts containing the expressed hybrid pyocins were spotted on a bacterial lawn of the S5-sensitive strain W15Dec1 to determine which protein was able to inhibit growth. The results (Fig. 3) show that only the second hybrid pyocin, S5-S2b, is able to kill the W15Dec1 sensitive strain (Fig. 3a) , suggesting that the receptor-binding domain of pyocin S5 lies between amino acids 150 and 300, and is not at the N-terminal end like in other S pyocins Michel-Briand & Baysse, 2002) . This result is in agreement with a previous secondary structure analysis of pyocin S5 (Ling et al., 2010) . The toxicity of the S5-S2b hybrid protein was further evaluated on different strains. One strain, J8, known to be immune to pyocin S2 was, as expected, resistant to the hybrid pyocin containing the S2 killing domain (Fig. 3b) . The W15Dec1DfptA transposon mutant was also insensitive due to the absence of the FptA receptor (Fig. 3c) .
B. cenocepacia is insensitive to pyocin S5
The opportunistic pathogen B. cenocepacia also produces the siderophore pyochelin and an FptA receptor highly similar (63 % identity, 76 % similarity) to the ferripyochelin receptor from P. aeruginosa (Farmer & Thomas, 2004; Mislin et al., 2006) . Fig. 4a shows the structure prediction of B. cenocepacia FptA based on the known P. aeruginosa FptA structure (Cobessi et al., 2005) . As these two receptors are similar we wanted to know whether B. cenocepacia could be sensitive to pyocin S5. However, all fptA-positive strains of B. cenocepacia tested were resistant to pyocin S5 (Fig. 4b, left photograph) . A BLAST search performed on known B. cenocepacia genomes (http://www.burkholderia. com) did not reveal the presence of a gene corresponding to the pyocin S5 immunity gene. We then introduced the P. aeruginosa fptA gene into B. cenocepacia in trans using the same plasmid described above, but the fptA heterodiploid strain was still resistant to S5, although to a lesser degree (Fig. 4b, right photograph) . To determine whether the B. cenocepacia fptA could be recognized by S5, we introduced the B. cenocepacia fptA gene into the P. aeruginosa DfptA mutant. The expression of the B. cenocepacia fptA gene in the P. aeruginosa DfptA mutant was confirmed by Reverse-transcription polymerase chain reaction (RT-PCR) (results not shown). The resultant P. aeruginosa strain with Bc FptA was, however, completely insensitive to S5 (Fig. 4c) . This result suggests that the fptA gene from B. cenocepacia is unable to restore the sensitivity to S5 in the P. aeruginosa fptA mutant, probably due to the differences in the structures of the receptors (Fig. 4d) .
DISCUSSION
Under conditions of iron limitation, different strains of P. aeruginosa become more susceptible to pyocins because iron-siderophore uptake receptors are involved in the pyocin uptake (de Chial et al., 2003; Denayer et al., 2007; Elfarash et al., 2012) . Analysis of S5-resistant transposon mutants revealed, for what is to the best of our knowledge the first time, that the bacteriocin utilizes the ferripyochelin receptor FptA. We also confirmed the prediction that the receptor-binding domain of S5 is not N-terminally located, but lies in the middle of the S5 pyocin protein as already suggested (Ling et al., 2010) , which represents a different domain organization compared to the other Stype pyocins. Interestingly, the constructed S5-S2b hybrid protein now became a pyocin with a DNase killing activity while recognizing FptA instead of the FpvAI ferripyoverdine receptor. Furthermore, the S5-type pyocin should have a broad range of killing activity in comparison to the other soluble pyocins, since the FptA receptor is probably present in the vast majority of P. aeruginosa strains. Indeed, when testing 61 clinical and environmental strains for their sensitivity to S5, we found that 50 were killed by S5, 10 of them being resistant because of the presence of the immunity gene in their genome (Table 3 and results not shown). The resistant strains lacking the immunity gene were confirmed by PCR to contain the fptA gene (results not shown). We also showed here that it is possible to construct hybrid pyocins having the S5 receptor-binding domain and different killing domains, hence further extending the bactericidal spectrum of the pyocin. Pyocin S5 and colicin 1b killing domains are similar (Cascales et al., 2005; Ling et al., 2010) . Colicin 1b recognizes the Cir outer membrane TonB-dependent receptor, which is involved in the uptake of linear catecholate siderophores, and then translocates throughout the periplasm (Jakes, 2012) . In the case of colicin 1a, it was shown that the Cir receptor is first contacted by the receptor-binding domain of the bacteriocin and that a second Cir protein is then used to translocate the colicin (Jakes, 2012) . Given the similar organization of
(c) Fig. 3 . Killing activity of the constructed hybrid pyocins on strains: W15Dec1 (a), J8 (b), and W15Dec1DfptA (c). None of the strains showed any sensitivity when S5-S2a was used because this hybrid pyocin does not have the receptor-binding domain of either pyocin. The J8 strain, which is sensitive to S5 while resistant to S2, was also resistant to S5-S2b as it expresses the pyocin S2 immunity protein. The W15Dec1 strain, which is sensitive to both pyocin S2 and S5, is sensitive to S5-S2b as it can enter the cell using the FptA-receptor-binding moiety of S5 and kill via the DNase domain of S2. The W15Dec1DfptA strain, which is sensitive to pyocin S2, was insensitive to S5-S2b due to the absence of the FptA receptor.
pyocin S5 and colicins 1a and 1b, we suggest a similar mechanism whereby FptA is used for the recognition by S5 while a second FptA is used for the translocation.
Not much is known about the regulation of pyocin S5 production, except that the DNA sequence upstream of the ORF does not contain the typical P box-like sequences, which are known to be bound by the PrtN activator (Michel-Briand & Baysse, 2002) . Recently, the region upstream of the PAO984 S5 immunity gene was found by chromatin immunoprecipitation to be bound by the OxyR protein . This is in agreement with the upregulation of pyocin S5 gene transcription after exposure to H 2 O 2 (Chang et al., 2005) . The construction of hybrid pyocins is a way to broaden the bactericidal activity of pyocins as was already demonstrated with hybrids containing the receptor-binding domain of S1 and the translocation and killing domain of S3 (Michel-Briand & Baysse, 2002 ). Here we show that it is possible to construct an active hybrid pyocin with the receptor-binding domain of S5 attached to the translocation and killing domains of S2. This hybrid pyocin has the advantage of being able to kill cells having the immunity gene against S5 and to use the well conserved ferripyochelin FptA receptor. Finally, we showed that B. cenocepacia FptA cannot be used as a receptor for the binding or the translocation of S5. A thorough analysis of the structures based on the known structure of P. aeruginosa FptA (Cobessi et al., 2005) using the PHYRE2 algorithm (Kelley & Sternberg, 2009 ) revealed some striking differences between the two ferripyochelin receptors (Fig. 4a, d ). Despite the overall high similarity at the level of amino acid sequence between the two proteins, clear differences can be seen at the level of the structures and sequences of the external loops (Fig. 4d) , which may explain why pyocin S5 is not recognizing the B. cenocepacia receptor protein. 
